5 Am Venture Management, LLC Avidity Biosciences, Inc. Transaction History

5 Am Venture Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$10.06 - $22.66 $2.77 Million - $6.23 Million	275,000 Added 70.41%	665,555 $14.8 Million
Q4 2021 Feb 03, 2022	SELL	$20.4 - $28.66 $3.37 Million - $4.73 Million	-165,000 Reduced 29.7%	390,555 $9.28 Million
Q3 2021 Nov 15, 2021	BUY	$18.16 - $25.21 $10.1 Million - $14 Million	555,555 New	555,555 $13.7 Million

256

107M

224K

161K

Ticker RNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,127,000
Market Cap $2.28B
Description
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...

Get notified when there are updates to the investment portfolio of 5 Am Venture Management, LLC, based on Form 13F filings with the SEC.

Stay updated on 5 Am Venture Management, LLC with notifications on news.